Showing results (741-750 of 843) with videos related to

Sort By:
Pageof 85
Nature Communications|June 19, 2026
Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteinsAaron J May, Muralikrishna Lella, Jared Lindenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.
The Journal of Infectious Diseases|May 29, 2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsDavid C Montefiori, Chitraporn Karnasuta, Ying Huang, et al.
Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adultsJames J Kobie, Wilton B Williams, William O Hahn, et al.
Science Translational Medicine|March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccinationNicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Clinical Investigation|February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adultsKristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Pageof 85